RecruitingNCT05112614
Role of Gut Microbiome in Cancer Therapy
Sponsor
Mayo Clinic
Enrollment
3,000 participants
Start Date
Sep 11, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria2
- Age 18-99
- Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancer therapy or undergoing stem cell transplant for any hematological condition
Exclusion Criteria2
- Unable to provide informed consent
- Vulnerable adults
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREBiospecimen Collection
Undergo collection of blood and stool samples
OTHERElectronic Health Record Review
Review of medical records
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05112614
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069740 locations
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
NCT06126276182 locations
Cancer Genetic Testing in Ethnic Populations
NCT044756402 locations
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401152 locations